Reference
·Primary source
Thai fertility IVF cross-border tourism revenue
THB 8-12B
Estimated 2026 revenue for Thai fertility, IVF and ART cross-border medical tourism. Insight derivation from RTCOG licensed-clinic list, Krungsri private hospital outlook, ESHRE pricing benchmark and clinic disclosures.
Figure in context
Estimated 2026 revenue for Thai fertility, IVF and ART cross-border medical tourism. Insight derivation from RTCOG licensed-clinic list, Krungsri private hospital outlook, ESHRE pricing benchmark and clinic disclosures.
Estimated 2026 revenue for Thai fertility, IVF and ART cross-border medical tourism. Insight derivation from RTCOG licensed-clinic list, Krungsri private hospital outlook, ESHRE pricing benchmark and clinic disclosures.
Time scope
2026E
Source basis
Primary source
Interpretation notes
What this tells you
Estimated 2026 revenue for Thai fertility, IVF and ART cross-border medical tourism. Insight derivation from RTCOG licensed-clinic list, Krungsri private hospital outlook, ESHRE pricing benchmark and clinic disclosures.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thai IVF international patient cycles
Clinic disclosures, RTCOG ART register, TAT medical tourism strategy
Thai fresh IVF cycle price (with ICSI)
ESHRE 2024 ART Fact Sheet, Superior A.R.T, Jetanin, Vejthani price lists
Thai full IVF course price (with PGT-A and FET)
ESHRE 2024 ART Fact Sheet, tier-1 clinic price lists
Thai licensed ART clinics
RTCOG ART Clinic Approved List 2024
Tier-1 operator share of credentialed cycle volume
Insight derivation from clinic disclosures, RTCOG register, BDMS, Vejthani SET filings
Thai fertility IVF tourism base-case CAGR through 2027
Insight derivation from clinic disclosures, Krungsri Research, TAT strategy
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.